
Federica Tavaglione
Articles
-
Dec 9, 2024 |
nature.com | Violeta Raverdy |Federica Tavaglione |Sami Qadri |Jimmy Vandel |Lisa Olsson |Joel Haas | +4 more
AbstractMetabolic dysfunction-associated steatotic liver disease (MASLD) exhibits considerable variability in clinical outcomes. Identifying specific phenotypic profiles within MASLD is essential for developing targeted therapeutic strategies. Here we investigated the heterogeneity of MASLD using partitioning around medoids clustering based on six simple clinical variables in a cohort of 1,389 individuals living with obesity.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →